Latest Breaking News On - Amarin pharma inc - Page 6 : comparemela.com

(BPT) - As the world looks with hope to the light at the end of the COVID-19 tunnel, there lies another ongoing health crisis that, according to the American Heart Association (AHA), kills more Americans than anything else: heart disease. In the last year, heart disease claimed more than 690,000 lives in the U.S., which is staggeringly more than the reported 345,000 lives lost to COVID-19, according to data from the Centers for Disease Control and Prevention. With the prevalence of this disease and the large amount of clinical data surrounding the management of CV risk factors, one would assume that the approaches used to reduce the risk of a CV event, such as a heart attack or stroke, would be standard practice. However, the overwhelming amount of information and data out there can actually make it hard to assess risk and treatment options, and it can be confusing for physicians, patients and caregivers to figure out what is best — especially when data changes old ways of th

United statesSouth lakeJohn osborneCenters for diseaseAmerican heart associationJournal of the american college cardiologyAmarin pharma incDisease controlHeart cardiologyAmerican collegeAtherosclerosis journalஒன்றுபட்டது மாநிலங்களில்தெற்கு ஏரிஜான் ஆஸ்போர்ன்மையங்கள் க்கு நோய்அமெரிக்கன் இதயம் சங்கம்